Parkinson’s Progression Markers Initiative

Parkinson’s Biomarker Initiative expands genetic study

Friday, March 27, 2015

The Parkinson’s Progression Markers Initiative (PPMI), a large-scale biomarker study sponsored by the Michael J. Fox Foundation for Parkinson’s Research (MJFF), is expanding to study individuals with a mutation of the GBA (glucosidase beta acid) gene. Participants will include people with or at increased risk to develop Parkinson’s disease. Researchers hope that a greater understanding of the biology and clinical features of these participants will lead to therapies benefiting all Parkinson’s patients and ultimately provide strategies to prevent disease onset.

[Read More]

UCSD enrolling in new arm of Parkinson’s Progression Markers Initiative

Wednesday, July 17, 2013

University of California, San Diego School of Medicine will be one of 23 official clinical sites of the Parkinson’s Progression Markers Initiative‘s (PPMI) new arm to study at-risk populations for Parkinson’s disease (PD). The $55 million landmark observational clinical study launched in 2010 to define one or more biomarkers of PD and now seeks to better understand potential risk factors of the disease. The university has been a part of PPMI for three years and currently is enrolling for the new, pre-motor arm of the study.

[Read More]